Your browser doesn't support javascript.
loading
Barriers and facilitators to the use of survivorship care plans by hematopoietic stem cell transplant survivors and clinicians.
Morken, Colleen; Tevaarwerk, Amye J; Juckett, Mark B; Swiecichowski, Amanda K; Haine, James E; Zhang, Xiao; Williams, Zachary T; Norslien, Kirsten; Campbell, Bethaney; Wassenaar, Timothy; Sesto, Mary E.
  • Morken C; University of Wisconsin, Madison, WI, USA.
  • Tevaarwerk AJ; University of Wisconsin, Madison, WI, USA.
  • Juckett MB; Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.
  • Swiecichowski AK; University of Wisconsin, Madison, WI, USA.
  • Haine JE; Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.
  • Zhang X; Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.
  • Williams ZT; University of Wisconsin, Madison, WI, USA.
  • Norslien K; Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.
  • Campbell B; Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.
  • Wassenaar T; Carbone Cancer Center, University of Wisconsin, Madison, WI, USA.
  • Sesto ME; Gilda's Club, Middleton, WI, USA.
Support Care Cancer ; 30(2): 1323-1330, 2022 Feb.
Article en En | MEDLINE | ID: mdl-34482447
PURPOSE: Survivors of hematopoietic stem cell transplants (HSCT) have complex care needs for the remainder of their lives, known as the survivorship period. Survivorship care plans (SCPs) have been proposed to improve care coordination and ultimately survivorship outcomes. We explored the barriers and facilitators of SCP use among HSCT survivors and their clinicians in order to develop more useful SCPs for the HSCT context. METHODS: Analogous surveys regarding perceived barriers to and facilitators of SCP use based on a sample SCP for a female allogenic HSCT survivor were administered to HSCT survivors and non-transplant oncology and primary care clinicians. RESULTS: Twenty-seven HSCT survivors and 18 clinicians completed the survey. The main barriers to SCP use were lack of awareness of SCP existence, uncertainty regarding where to find SCP, unclear roles and responsibilities among healthcare teams, length of SCP, and difficultly understanding SCPs. The facilitators of SCP use were increased understanding of survivorship care needs, clarified roles and responsibilities of survivors and clinicians, SCPs that are readily available and searchable in electronic health record, increased awareness of SCP existence and provision to all survivors, and if the SCP is survivor-specific and up-to-date. CONCLUSIONS: Much of the work regarding SCPs has looked at barriers to creation and provision; however, our study examines factors influencing use of SCPs. By determining the barriers and facilitators surrounding SCP use for HSCT survivors and their clinicians, we can create SCP templates and clinical workflows to optimize SCP use, ideally leading to better outcomes for HSCT survivors.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Neoplasias Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Neoplasias Límite: Female / Humans Idioma: En Año: 2022 Tipo del documento: Article